Plain-English translation of NCT05366881 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new blood test that looks for signs of cancer by analyzing pieces of DNA circulating in your bloodstream. The test is designed to detect cancer early, monitor whether cancer remains after treatment, and catch cancer if it comes back. Researchers want to understand how accurate and useful this blood test can be for patients with many different types of cancer.
Current ways to find cancer or check if treatment worked often rely on imaging scans or waiting for symptoms to appear—both of which can miss cancer in early stages or take time to show results. This medication-free blood test could offer a faster, simpler way to catch cancer earlier and track whether patients are staying cancer-free after treatment.
You likely qualify if…
You likely don't qualify if…
At your first visit, you'll give a blood sample and share relevant medical information. If you have cancer, you'll have follow-up blood draws and clinical visits after your treatment ends—every 3 months for the first year, then every 6 months for 2 more years. If you don't have cancer, you'll have check-in visits every 6 months for up to 3 years to confirm you remain cancer-free. The blood samples will be tested using the new technology, though the results won't be shared back to you or your doctor as part of this study.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States